Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Improving the Outcomes of Immunocompromised Patients With Coronavirus Disease 2019
Ghady Haidar, John W. Mellors
Clinical Infectious Diseases (2021) Vol. 73, Iss. 6, pp. e1397-e1401
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

COVID-19: Challenges of Viral Variants
Jana L. Jacobs, Ghady Haidar, John W. Mellors
Annual Review of Medicine (2022) Vol. 74, Iss. 1, pp. 31-53
Open Access | Times Cited: 87
COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies
Manuela Di Fusco, Jay Lin, Shailja Vaghela, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 4, pp. 435-451
Open Access | Times Cited: 82
Humoral and Cellular Response Following Vaccination With the BNT162b2 mRNA COVID-19 Vaccine in Patients Affected by Primary Immunodeficiencies
Donato Amodio, Alessandra Ruggiero, Mayla Sgrulletti, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 88
Immunocompromised Patients with Protracted COVID-19: a Review of “Long Persisters”
M. Veronica Dioverti, Sonsoles Salto‐Alejandre, Ghady Haidar
Current Transplantation Reports (2022) Vol. 9, Iss. 4, pp. 209-218
Open Access | Times Cited: 60
Monkeypox (mpox) in immunosuppressed patients
Sirwan Khalid Ahmed, Mona Gamal Mohamed, Eman Abdelaziz Rashad Dabou, et al.
F1000Research (2023) Vol. 12, pp. 127-127
Open Access | Times Cited: 40
The immune response to SARS-CoV-2 in people with HIV
Maxine A. Höft, Wendy A. Burgers, Catherine Riou
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 184-196
Open Access | Times Cited: 36
Exploring the Dynamics of SARS-CoV-2 and HIV Co-infection: Mutation Risks, Therapeutic Efficacy, and Future Variant Prevention
Sumaiya Tasnim Maliha, Rabeya Fatemi, Marjana Akter, et al.
Diagnostic Microbiology and Infectious Disease (2025) Vol. 111, Iss. 3, pp. 116707-116707
Closed Access | Times Cited: 1
Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2
Manuela Di Fusco, Mary M. Moran, Alejandro Cané, et al.
Journal of Medical Economics (2021) Vol. 24, Iss. 1, pp. 1248-1260
Open Access | Times Cited: 53
Persistent SARS-CoV-2 infection in immunocompromised patients facilitates rapid viral evolution: Retrospective cohort study and literature review
David Hettle, Stephanie Hutchings, Peter Muir, et al.
Clinical Infection in Practice (2022) Vol. 16, pp. 100210-100210
Open Access | Times Cited: 34
Genetic and immunologic evaluation of children with inborn errors of immunity and severe or critical COVID-19
Hassan Abolhassani, Samaneh Delavari, Nils Landegren, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 150, Iss. 5, pp. 1059-1073
Open Access | Times Cited: 32
Monkeypox (mpox) in immunosuppressed patients
Sirwan Khalid Ahmed, Mona Gamal Mohamed, Eman Abdelaziz Rashad Dabou, et al.
F1000Research (2023) Vol. 12, pp. 127-127
Open Access | Times Cited: 19
Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer
Arielle Elkrief, Julie Wu, Chinmay Jani, et al.
Cancer Discovery (2021) Vol. 12, Iss. 2, pp. 303-330
Open Access | Times Cited: 35
Immunizing the imperfect immune system
Jessica Durkee-Shock, Michael D. Keller
Annals of Allergy Asthma & Immunology (2022) Vol. 129, Iss. 5, pp. 562-571.e1
Open Access | Times Cited: 26
Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis
Mohammad-Mehdi Mehrabi Nejad, Parnian Shobeiri, Hojat Dehghanbanadaki, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 24
Egg Yolk Antibody for Passive Immunization: Status, Challenges, and Prospects
Huiwen Wang, Qixin Zhong, Jun Lin
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 13, pp. 5053-5061
Closed Access | Times Cited: 15
Sequence-based diagnostics and precision medicine in bacterial and viral infections: from bench to bedside
Jonathan Pham, LingHui David Su, Kimberly E. Hanson, et al.
Current Opinion in Infectious Diseases (2023) Vol. 36, Iss. 4, pp. 228-234
Closed Access | Times Cited: 11
Humoral immunogenicity and tolerability of heterologous ChAd/BNT compared with homologous BNT/BNT and ChAd/ChAd SARS-CoV-2 vaccination in hemodialysis patients
Michael Haase, Paul Lesny, Mark Anderson, et al.
Journal of Nephrology (2022) Vol. 35, Iss. 5, pp. 1467-1478
Open Access | Times Cited: 17
Key insights into recent advances and challenges in COVID-19 management
Prakash Monika, Anushka A. Poola, Prithvi S. Prabhu, et al.
Deleted Journal (2025) Vol. 22, Iss. 1
Open Access
Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients: An Observational, Prospective Cohort Study Interim Analysis
Ghady Haidar, Mounzer Agha, Amy Lukanski, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 23
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials
Ilias Ι. Siempos, André C. Kalil, Drifa Belhadi, et al.
EClinicalMedicine (2024) Vol. 69, pp. 102472-102472
Open Access | Times Cited: 3
A cohort study of COVID-19 infection in pediatric oncology patients plus the utility and safety of remdesivir treatment
Rina Yue Ling Ong, Valerie Xue Fen Seah, Chia Yin Chong, et al.
Acta Oncologica (2023) Vol. 62, Iss. 1, pp. 53-57
Open Access | Times Cited: 8
Efficacy of sotrovimab for persistent coronavirus disease-2019 in a severely immunocompromised person living with HIV
Rocío Montejano, Cristina Marcelo, Iker Falces‐Romero, et al.
AIDS (2022) Vol. 36, Iss. 5, pp. 751-753
Open Access | Times Cited: 10
Safety and efficacy of tixagevimab/cilgavimab for pre-exposure prophylaxis in kidney transplant recipients: a multicenter retrospective cohort study
Simona Simone, Virginia Pronzo, Francesco Pesce, et al.
Journal of Nephrology (2024) Vol. 37, Iss. 6, pp. 1539-1550
Open Access | Times Cited: 2
Estimated Health Outcomes and Costs of COVID-19 Prophylaxis With Monoclonal Antibodies Among Unvaccinated Household Contacts in the US
Abraham D. Flaxman, Rodal Issema, Ruanne V. Barnabas, et al.
JAMA Network Open (2022) Vol. 5, Iss. 4, pp. e228632-e228632
Open Access | Times Cited: 10
Impact of the COVID‐19 pandemic on patients with myasthenia gravis: A survey of the Myasthenia Gravis Foundation of America MG patient registry
Andrés De León-Benedetti, Inmaculada Aban, Tarrant McPherson, et al.
Muscle & Nerve (2022) Vol. 67, Iss. 1, pp. 25-32
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top